Takashi Kei Kishimoto - Jan 4, 2023 Form 4 Insider Report for SELECTA BIOSCIENCES INC (SELB)

Role
Chief Scientific Officer
Signature
/s/ Matthew Bartholomae, Attorney-in-Fact for Takashi Kei Kishimoto
Stock symbol
SELB
Transactions as of
Jan 4, 2023
Transactions value $
-$11,077
Form type
4
Date filed
1/6/2023, 04:15 PM
Previous filing
Jan 4, 2023
Next filing
Jun 1, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SELB Common Stock Sale -$7.23K -6.38K -1.71% $1.13 368K Jan 4, 2023 Direct F1
transaction SELB Common Stock Sale -$13 -11 0% $1.15 368K Jan 4, 2023 Direct F1
transaction SELB Common Stock Sale -$3.81K -3.37K -0.92% $1.13 364K Jan 5, 2023 Direct F1
transaction SELB Common Stock Sale -$22 -20 -0.01% $1.11 364K Jan 5, 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares sold to satisfy withholding tax obligations upon the vesting of restricted stock units and to cover related broker fees.